Can-Fite BioPharma Ltd. (ADR)
General ticker "CANF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $7.1M (TTM average)
Can-Fite BioPharma Ltd. (ADR) does not follow the US Stock Market performance with the rate: -34.4%.
Estimated limits based on current volatility of 5.6%: low 0.33$, high 0.37$
Factors to consider:
- Total employees count: 9 as of 2013
- Current price 75.4% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.41$, 3.76$]
- 2024-12-30 to 2025-12-30 estimated range: [1.38$, 3.68$]
Financial Metrics affecting the CANF estimates:
- Positive: with PPE of -1.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -93.32 <= 0.33
- Positive: 41.86 < Shareholder equity ratio, % of 62.50 <= 63.39
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 5.51 > -0.66
- Positive: Interest expense per share per price, % of 0.15 <= 0.79
Short-term CANF quotes
Long-term CANF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.81MM | $0.74MM | $0.67MM |
| Operating Expenses | $10.91MM | $8.94MM | $8.80MM |
| Operating Income | $-10.10MM | $-8.20MM | $-8.13MM |
| Non-Operating Income | $-0.08MM | $0.56MM | $0.25MM |
| Interest Expense | $0.02MM | $0.01MM | $0.01MM |
| R&D Expense | $7.76MM | $5.98MM | $5.76MM |
| Income(Loss) | $-10.17MM | $-7.63MM | $-7.88MM |
| Profit(Loss)* | $-10.17MM | $-7.63MM | $-7.88MM |
| Stockholders Equity | $4.47MM | $6.24MM | $5.44MM |
| Inventory | $0.04MM | $0.00MM | $0.00MM |
| Assets | $9.28MM | $9.99MM | $9.12MM |
| Operating Cash Flow | $-10.80MM | $-8.44MM | $-7.64MM |
| Capital expenditure | $0.01MM | $0.00MM | $0.01MM |
| Investing Cash Flow | $9.50MM | $0.50MM | $1.50MM |
| Financing Cash Flow | $0.00MM | $9.14MM | $6.71MM |
| Earnings Per Share** | $-3.74 | $-1.79 | $-1.09 |
| Ordinary share to ADR | 0.00x | 0.00x | 0.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.